NanoDDS'10 - DelScience

TPI to Host Second Quarter of Fiscal Year 2012 Earnings Conference Call on Tuesday, February 14, 2012 at 8:30 a.m. ET 5 Feb 2012 | 9:08 am
CHENGDU, China, Feb. 5, 2012 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in…
Organ Donation Association Supports Living Organ Donation 5 Feb 2012 | 6:26 am
VIENNA, Va., Feb. 5, 2012 /PRNewswire/ -- Currently, there are more than 112,000 patients on the national organ transplant waiting…
New Science in Skin Care Available to Consumers 4 Feb 2012 | 5:42 pm
WILMINGTON, Del., Feb. 4, 2012 /PRNewswire-iReach/ -- Prolastil.com Prolastil Skin Cream and Eye Serum Scientific Update The products, marketed under…
Argos Therapeutics Announces New Data Demonstrating Prolonged Overall Survival in a Phase 2 Study of its Arcelis™ Immunotherapy AGS-003 in Combination with Sunitinib in Patients with Metastatic Renal Cell Carcinoma (mRCC) 4 Feb 2012 | 2:30 pm
DURHAM, N.C., Feb. 4, 2012 /PRNewswire/ -- Argos Therapeutics Inc. today announced that updated results from an open label Phase 2…
USCCB: White House Misrepresents its Own Contraceptive Mandate 4 Feb 2012 | 12:02 pm
WASHINGTON, Feb. 4, 2012 /PRNewswire-USNewswire/ -- The U.S. Conference of Catholic Bishops has issued the following response to the February…

Event
When:	03.10.2010 - 05.10.2010
Event title	NanoDDS\'10
Where:	Hilton Omaha - Omaha, NE
Category:	Symposia

Event description:
Organized by the University of Nebraska Center for Drug Delivery and Nanomedicine, the conference aims to deliver nanomedicine and drug delivery science from lab to clinics. This year symposia is divided into 5 sessions: Nanomedicine in cancer (part I and II) Clinical translation of nanomedicines Novel nanoformulation Technologies Tackling Nanomaterial–Tissue Interfaces to Improve Therapies and Diagnostics Nanomedicine Research Reports http://www.nanodds.org/template_view.cfm?PageID=1